Occupational Therapists in Elsmere, KY Accepting Medicare
3 Occupational Therapists found. Showing 1 - 3
 Lilly A Bradley Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3802 Turkeyfoot Rd, Elsmere, KY 41018 Phone: 859-342-0200 |
Heather Renee Ratchford-simms, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3876 Turkeyfoot Rd, Elsmere, KY 41018 Phone: 859-344-8775 Fax: 859-342-0861 |
Miss Erin Pyle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3208 Turkeyfoot Rd, Elsmere, KY 41018 Phone: 859-342-0200 |
News Archive
First period before age of 10 linked to lower lung capacity later in life
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
Pre-malignant mammary lesions in dogs and humans display many of the same characteristics
...a discovery that could lead to better understanding of breast cancer progression and prevention for people and pets, said a Purdue University scientist from the School of Veterinary Medicine.
10 GOP senators want Sebelius to be fired; some Democratic senators beginning to press for individual mandate delay
Health law politics are triggering a new wave of political posturing among lawmakers who are attempting to position themselves for the upcoming election season.
Scientists discover that foot callouses can be linked to oesophageal cancer
Scientists from Queen Mary University of London have discovered that foot callouses/keratoderma (thickened skin) can be linked to cancer of the oesophagus (gullet), a disease which affects more than 8000 people in the UK each year.
OptiNose to initiate novel intranasal technology Phase III trials in acute migraine
OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration (FDA) in December, 2011. The FDA has completed its review and has notified OptiNose that the studies under this IND may proceed. The Company will initiate Phase III trials in adults with acute migraine with or without aura utilizing its novel intranasal technology.
› Verified 4 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Speech-Language Pathologists